| Protein Name | Dynactin Subunit 2 (p50) |
|---|---|
| Gene | [DCTN2](/genes/dctn2) |
| UniProt | Q13596 |
| Length | ~400 amino acids |
| Complex | [Dynactin](/proteins/dynactin-protein) shoulder module |
| Primary System Relevance | Neuronal retrograde axonal transport |
The DCTN2 protein (often called p50) is a structural subunit of the dynactin complex, which acts with cytoplasmic dynein to move cargo toward microtubule minus ends.[1][2] In neurons, this machinery enables long-range retrograde transport required for signaling, organelle quality control, and waste clearance.[3][4]
DCTN2 localizes to the dynactin shoulder region, where it contributes to stable assembly of dynein-dynactin-adaptor transport units.[1:1][2:1] Unlike catalytic enzymes, DCTN2 functions primarily as an architectural element that helps position interacting subunits and maintain the geometry required for processive motility.
Biochemical and structural studies of dynein-dynactin complexes indicate that small changes in subunit stoichiometry can alter run length, force production, and cargo engagement efficiency.[1:2][2:2] Although most of these experiments are complex-level rather than DCTN2-only perturbations, they support a model in which DCTN2 integrity is necessary for robust long-distance transport.
In long axons, DCTN2-containing dynactin complexes contribute to:
Failure of these routes can produce distal axonal swellings, delayed clearance of damaged cargoes, and reduced trophic support, each a recurrent feature of vulnerable neuronal populations in neurodegeneration.[4:2][5:1]
Transport defects intersect with protein aggregation and autophagy pathways. When dynein-dynactin throughput is reduced, aggregate-prone species are more likely to persist in neurites, increasing downstream stress signaling and synaptic dysfunction.[4:3][5:2]
Current strategy is to target transport network function rather than DCTN2 directly:
Urnavicius L, et al. Cryo-EM shows how dynactin recruits two dyneins for faster movement. Nature. 2018. ↩︎ ↩︎ ↩︎
Schlager MA, et al. In vitro reconstitution of a highly processive recombinant human dynein complex. EMBO J. 2014. ↩︎ ↩︎ ↩︎
Moughamian AJ, Holzbaur ELF. Dynactin is required for transport initiation from the distal axon. Neuron. 2014. ↩︎ ↩︎ ↩︎
Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci. 2008. ↩︎ ↩︎ ↩︎ ↩︎
Farrer MJ, et al. DCTN1 mutations in Perry syndrome. Nat Genet. 2009. ↩︎ ↩︎
Hoang HT, et al. Mutations in the motor domain of DYNC1H1 cause dominant spinal muscular atrophy. Ann Neurol. 2017. ↩︎